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Purpose: Several authors point out some substantial 
differences in the biological response invoked by proton 
beam and X-rays [1][2]. Beside differences in short-term 
effects such as DNA repair [3], also some long-term cellular 
and tissue properties are differentially affected, such as 
angiogenesis [4], or metastasis  [5]. We aimed at studying the 
migratory properties of human melanoma cells after low 
doses of proton beam radiation. 
Materials/methods: BLM human melanoma cells (derived 
from lung metastasis) were irradiated with 1-5 Gy of X ray 
(300 kVp Phillips, 1Gy/min) or proton beam (58 MeV) from 
Proteus C-235 cyclotron. Cells were analyzed for migratory 
and motility properties  using time-lapse monitoring of 
individual cell movements, Boyden chamber assay and the 
wound test. To check if these effects were long-term, the 
same tests were performed  at day 20 and 40 after 
irradiation. Cell stiffness was assessed using AFM method. 
Results: BLM cells exhibited lower displacement after proton 
beam and slightly higher after X rays. Boyden chamber assay 
and wound test indicated lower migration rate after proton 
beam and higher after X rays. In agreement with these 
results, cells treated with proton beam revealed decreasing 
cell stiffeness with dose as well. 
Conclusions: In contrast to X rays, low doses of proton beam 
irradiation inhibited the long-term migratory properties 
affecting their directionality and invasion potential. 
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The requirements for early diagnostics as well as effective 
treatment of cancers constantly increase the pressure on 
development of efficient and reliable methods for targeted 
radiotherapy as well as imaging of the success of the 
treatment. Recently, new nanotechnology-based approaches 
have been explored for more efficient delivery of therapeutic 
radionuclides. Nanocarriers allow delivery of the 
radionuclides not only into the tumour tissue but all the way 
inside the tumour cells, which increases cytotoxic efficacy of 
the treatment1. 
In the aim of targeted radiotherapy and imaging, new 
methods combining radionuclides and mesoporous silicon 
(PSi) nanoparticles are being developed. PSi nanoparticles 
present major advantages for localised radiotherapy. Indeed, 
mesoporous silicon can tolerate high temperatures keeping 
its properties, which makes it an optimal material for 
particle activation. Moreover, its high adsorption capacity 
with anti-cancer drugs combined with further modification of 
the nanoparticles with tumour targeting moieties allow 
delivery of therapeutically relevant doses into the tumour 
tissue with a minimum amount of particles. By selecting 
therapeutic radionuclides that are applicable for nuclear 
imaging, trafficking of the administrated chemoradiotherapy 
nanovectors can be followed by non-invasive imaging 
whether with single emission computed tomography (SPECT) 
or positron emission tomography (PET). In order to aim these 
objectives two different approaches were implemented: 
implantation of the nuclide of interest into the PSi 
nanoparticles followed by its activation or direct 
implantation of the radioisotope of interest into PSi 
The stability of the particles in buffer solutions with different 
physiologically relevant pH as well as the stability of the 
implanted nuclei in the particles were studied. The 
developed methods, first results of these studies and 
perspectives on this new therapeutical approach will be 
presented here. 
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Purpose: Radio-guided surgery (RGS) is a technique adopted 
by the surgeon to perform a complete lesion resection, 
taking advantage from the uptake from the tumor of 
specific radiolabelled tracers. Established methods make 
use of γ emitting tracer and γ radiation detection probe. To 
extend the applicability of RGS, we are developing an 
innovative technique exploiting β- radiation [1]. It 
penetrates only a few mm resulting both in a lower required 
radio-pharmaceutical activity and the possibility to apply 
the technique also to cases with a large uptake of nearby 
healthy organs. Low background rate is also correlated with 
low medical team exposure. 
Methods: We developed and tested several prototypes of 
the intraoperative β- probe, the core made of para-
terphenyl scintillator. The readout electronics is 
portable and customized to match the surgeon needs, 
with 
 
